ERBB2 and neoplasm: In two cases, HER2 was amplified and overexpressed in the primary tumour, but not in distant BM micrometastatic cells and in one case, HER2 presented a very low level of amplification in BM micrometastatic cells (six copies) and not in the primary tumour (two copies).